AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,520,000 | -12.4% | 78,895 | -24.8% | 3.06% | -26.5% |
| Q2 2022 | $4,017,000 | -9.4% | 104,889 | -2.1% | 4.16% | +29.1% |
| Q1 2022 | $4,436,000 | +2.5% | 107,187 | -6.4% | 3.23% | +21.5% |
| Q4 2021 | $4,327,000 | +15.7% | 114,525 | +1.0% | 2.66% | +7.7% |
| Q3 2021 | $3,739,000 | -18.3% | 113,430 | +67.2% | 2.47% | -18.0% |
| Q2 2021 | $4,576,000 | +53.5% | 67,835 | +28.8% | 3.01% | +43.9% |
| Q1 2021 | $2,981,000 | -17.7% | 52,658 | +18.4% | 2.09% | -27.6% |
| Q4 2020 | $3,623,000 | +30.3% | 44,468 | +14.0% | 2.88% | +4.0% |
| Q3 2020 | $2,780,000 | -14.1% | 39,018 | -0.8% | 2.77% | -21.0% |
| Q2 2020 | $3,236,000 | +29.7% | 39,328 | -7.2% | 3.51% | +8.3% |
| Q1 2020 | $2,495,000 | +339.3% | 42,402 | +670.9% | 3.24% | +482.4% |
| Q4 2019 | $568,000 | – | 5,500 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |